Eltrombopag for secondary failure of platelet recovery post-allogeneic hematopoietic stem cell transplant in children. (avaa uuden ikkunan)

Ali S, Gassas A, Kirby-Allen M, Krueger J, Ali M, Schechter T

Lähde‎: Pediatr Transplant 2017;21(6):e13017.

Arkistoitu‎: PubMed 28653480

DOI‎: 10.1111/petr.13017

https://www.ncbi.nlm.nih.gov/pubmed/28653480 (avaa uuden ikkunan)

The role of interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with solid tumors, lymphoma, acute myeloid leukemia and bone marrow failure syndromes. (avaa uuden ikkunan)

Bhatia M, Davenport V, Cairo MS.

Lähde‎: Leuk Lymphoma 2007;48(1):9-15.

Arkistoitu‎: PubMed 17325843

DOI‎: 10.1080/10428190600909115

https://www.ncbi.nlm.nih.gov/pubmed/17325843 (avaa uuden ikkunan)

Recombinant human interleukin 11 and bacterial infection in patients with haematological malignant disease undergoing chemotherapy: a double-blind placebo-controlled randomised trial. (avaa uuden ikkunan)

Ellis M, Zwaan F, Hedström U, Poynton C, Kristensen J, Jumaa P, Wassell J, al-Ramadi B.

Lähde‎: Lancet 2003;361(9354):275-80.

Arkistoitu‎: PubMed 12559860

https://www.ncbi.nlm.nih.gov/pubmed/12559860 (avaa uuden ikkunan)

Romiplostim for immune thrombocytopenia in neuroblastoma patients receiving chemotherapy. (avaa uuden ikkunan)

Fassel H, Bussel JB, Roberts SS, Modak S

Lähde‎: J Pediatr Hematol Oncol 2019;41(4):e257-9.

Arkistoitu‎: PubMed 29683946

DOI‎: 10.1097/MPH.0000000000001187

https://www.ncbi.nlm.nih.gov/pubmed/29683946 (avaa uuden ikkunan)

Romiplostim for therapy-related thrombocytopenia in pediatric malignancies. (avaa uuden ikkunan)

Jacobson AE, Shah N, Setty BA

Lähde‎: Pediatr Blood Cancer 2017;64(8):e26473.

Arkistoitu‎: PubMed 28150377

DOI‎: 10.1002/pbc.26473

http://www.ncbi.nlm.nih.gov/pubmed/28150377 (avaa uuden ikkunan)

Eltrombopag for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantation in children. (avaa uuden ikkunan)

Li S, Wu R, Wang B, Fu L, Zhu G, Zhou X, Ma J, Zhang L, Qin M

Lähde‎: J Pediatr Hematol Oncol 2019;41(1):38-41.

Arkistoitu‎: PubMed 30080752

DOI‎: 10.1097/MPH.0000000000001263

https://www.ncbi.nlm.nih.gov/pubmed/30080752 (avaa uuden ikkunan)

Romiplostim for secondary thrombocytopenia following allogeneic stem cell transplantation in children. (avaa uuden ikkunan)

Maximova N, Zanon D, Rovere F, Maestro A, Schillani G, Paparazzo R

Lähde‎: Int J Hematol 2015;102(5):626-32.

Arkistoitu‎: PubMed 26084627

DOI‎: 10.1007/s12185-015-1821-1

https://www.ncbi.nlm.nih.gov/pubmed/26084627 (avaa uuden ikkunan)

Recombinant human erythropoietin reduces the need for erythrocyte and platelet transfusions in pediatric patients with sarcoma: a randomized, double-blind, placebo-controlled trial. (avaa uuden ikkunan)

Porter JC, Leahey A, Polise K, Bunin G, Manno CS

Lähde‎: J Pediatr 1996;129(5):656-60.

Arkistoitu‎: PubMed 8917229

DOI‎: 10.1016/s0022-3476(96)70145-2

https://www.ncbi.nlm.nih.gov/pubmed/8917229 (avaa uuden ikkunan)

Chemotherapy induced thrombocytopenia in pediatric oncology. (avaa uuden ikkunan)

Tamamyan G, Danielyan S, Lambert MP

Lähde‎: Crit Rev Oncol Hematol 2016;99:299-307.

Arkistoitu‎: PubMed 26811139

DOI‎: 10.1016/j.critrevonc.2016.01.005

https://www.ncbi.nlm.nih.gov/pubmed/26811139 (avaa uuden ikkunan)

Oncological management of pediatric cancer patients belonging to Jehovahs Witnesses: a two-institutional experience report. (avaa uuden ikkunan)

Tenenbaum T, Hasan C, Kramm CM, Janssen G, Laws HJ, Wessalowski R, Bode U, Göbel U

Lähde‎: Onkologie 2004;27(2):131-7.

Arkistoitu‎: PubMed 15138344

DOI‎: 10.1159/000076901

https://www.ncbi.nlm.nih.gov/pubmed/15138344 (avaa uuden ikkunan)

Low-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experience. (avaa uuden ikkunan)

Tsimberidou AM, Giles FJ, Khouri I, Bueso-Ramos C, Pilat S, Thomas DA, Cortes J, Kurzrock R.

Lähde‎: Ann Oncol 2005;16(1):139-45.

Arkistoitu‎: PubMed 15598951

DOI‎: 10.1093/annonc/mdi007

https://www.ncbi.nlm.nih.gov/pubmed/15598951 (avaa uuden ikkunan)

Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. (avaa uuden ikkunan)

Wandt H, Frank M, Ehninger G, Schneider C, Brack N, Daoud A, Fackler-Schwalbe I, Fischer J, Gäckle R, Geer T, Harms P, Löffler B, Ohl S, Otremba B, Raab M, Schönrock-Nabulsi P, Strobel G, Winter R, Link H

Lähde‎: Blood 1998;91(10):3601-6.

Arkistoitu‎: PubMed 9572994

https://www.ncbi.nlm.nih.gov/pubmed/9572994 (avaa uuden ikkunan)